eMedicine Specialties > Gastroenterology > Intestine

Diverticulosis, Small Intestinal: Treatment & Medication

Author: Lisa Ozick, MD, Chief, Division of Gastroenterology, Harlem Hospital Center
Coauthor(s): Rohan C Clarke, MD, Attending Gastroenterologist, JPS Health Systems Hospital, Fort Worth, Texas; Oluyinka S Adediji, MD, Consulting Staff, Department of Adult and General Medicine, Health Services Incorporated, Montgomery, Alabama
Contributor Information and Disclosures

Updated: Apr 12, 2006

Treatment

Medical Care

The general recommendation favors a conservative approach to the management of asymptomatic diverticula. They are generally left alone unless they can be related to diseases. In certain locations, diverticula are associated with special complications. For example, periampullary diverticula can be associated with pancreatitis, cholangitis, or recurrent choledocholithiasis after cholecystectomy. Intraluminal diverticula are observed in the duodenum. They can be complicated by intestinal obstruction and biliary and pancreatic diseases. A higher complication rate is associated with jejunoileal diverticulosis and, as such, may justify less conservative approach to its management. Capsule endoscopy might be of value if available to identify the site of the bleed. Push enteroscopy should be used once a lesion amenable to therapeutic intervention has been identified.

  • Prehospital care: Acute abdomen and obvious and occult GI hemorrhage are the clinical scenarios that necessitate prehospital intervention. Vascular access, intravenous fluid, oxygen, and prompt transport to the hospital are all that is required in the field.
  • Medical management
    • Abdominal pain without clinical evidence of diverticulitis or intestinal obstruction requires no specific treatment. Patients benefit from the use of bulk-forming agents, such as fiber, bran, and cellulose products. Intractable pain associated with anemia and jejunal loop dilatation on radiograph should heighten concern for jejunal diverticulosis.
    • For diverticulitis, patients often require hospitalization because preoperative diagnosis of small bowel diverticulitis is difficult. Initial interventions include the following:
      • Bed rest
      • Nothing by mouth and/or nasogastric suctioning
      • IV fluid
      • Broad-spectrum antibiotic coverage
      • Surgical consultation: Urgent surgery rarely is indicated unless perforation, abscess, or neoplasm is suspected.
  • Management of complications: The approach to management of complicated small bowel diverticula involves initiation of medical and supportive management. Surgical consultation must be performed promptly. Patients can present with the following complications:
    • GI bleeding and/or hemorrhage
      • Patient is treated with IV fluid and blood products as necessary.
      • Diagnostic workup is usually completed in the intensive care setting.
      • Most patients stop bleeding, allowing elective surgery.
      • Mesenteric angiography with infusion of vasoconstrictors can be used in persistent hemorrhage.
      • Laparotomy may be indicated as an emergency therapy for continuing bleeding or as elective treatment if bleeding responds to conservative management.
    • Intestinal perforation: Early surgery is the treatment of choice. Fluid and electrolyte management as well as antibiotics are essential adjuncts.
    • Intestinal obstruction: Initial management is similar to uncomplicated diverticulitis. Urgent surgical consultation is mandatory.
    • Intestinal pseudoobstruction: Cautious conservative management is indicated while excluding mechanical obstruction.
    • Fistula formation: This is a rare complication.
    • Malabsorption: This is often a complication of bacterial overgrowth resulting from blind loop syndrome. It usually responds to antibiotics.
    • Preoperative diagnosis of diverticula is seldom made. This can present as intussusception, volvulus, or pseudoobstruction.

Surgical Care

  • Complications of small bowel diverticulosis, such as massive bleeding or diverticulitis with perforation, require surgery. Diagnosis is seldom made preoperatively. The aim is to control complications when present and/or to prevent future complications.
  • Emergency surgery is indicated for severe diverticulitis, intestinal perforation, intestinal obstruction, and hemorrhage that continue after conservative management.
  • Several operative procedures are available depending on the type of diverticulum, site, and nature of complications.
  • Simple diverticulectomy
    • This is most commonly used for symptomatic diverticulum or bleeding diverticulum of the duodenum. The diverticulum is simply excised, and the bowel is closed longitudinally or transversely, ensuring minimal luminal stenosis.
    • This procedure requires modification in cases involving a diverticulum that is embedded deep in the head of the pancreas or is associated with the ampulla of Vater, is perforated, or is intraluminal in location. It can be technically difficult in the presence of common duct obstruction. These patients benefit more from choledochoduodenostomy.
    • Meckel diverticulum can also be removed by this technique.
  • Intestinal resection and end-to-end anastomosis: This is the preferred approach to jejunoileal diverticulum, which tends to be multiple, irrespective of types of complications.
  • Enterotomy: This can be performed solely to remove enterolith of diverticular origin causing distal obstruction.
  • Caveats of surgical management: Perforated duodenal diverticulum requires a special approach. Simple excision and closure may be complicated by obstruction; therefore, consider complete diversion of the bowel from the duodenum, then perform vagotomy, antrectomy, closure of the duodenal loop, and Billroth II anastomosis. Dysmotility alone without obstruction is not an indication for bowel resection because resection would not prevent propagation of motility disorder.

Consultations

  • Consultation with a general surgeon is indicated for all patients requiring surgical management.
  • A gastroenterologist assists with diagnosis and follow-up strategy and performs both diagnostic and therapeutic endoscopy.

Diet

The role of diet is not clear. A high-fiber diet that improves bowel motility and is used in colonic diverticulosis may be beneficial.

Activity

No restriction of activity is indicated.

Medication

Antibiotics are important in the management of diverticulitis and related complications.

Antibiotics

Empiric antimicrobial therapy must be comprehensive and should cover all likely pathogens in the clinical setting. Antibiotic combinations are usually recommended for serious gram-negative bacillary infections. This approach ensures coverage for a broad range of organisms and polymicrobial infections. In addition, it prevents resistance from bacterial subpopulations and provides additive or synergistic effects. Once organisms and sensitivities are known, the use of antibiotic monotherapy is then recommended. Antibiotics can be administered PO in mild disease and unambiguous diagnosis, otherwise administer IV.


Metronidazole (Flagyl)

Active against various anaerobic bacteria and protozoa. Appears to be absorbed into the cells and the intermediate metabolized compounds that are formed, binding DNA and inhibiting protein synthesis, which causes cell death.

Adult

15 mg/kg IV loading dose, followed by 500 mg PO/IV q6h

Pediatric

Not established

Cimetidine may increase toxicity of metronidazole; may increase effects of anticoagulants; may increase toxicity of lithium and phenytoin; disulfiramlike reaction may occur with orally ingested ethanol

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Adjust dose in hepatic disease; monitor for seizures and development of peripheral neuropathy


Clindamycin (Cleocin)

Effective against aerobic and anaerobic streptococci but not enterococci. Inhibits bacterial protein synthesis by inhibiting peptide chain initiation at the bacterial ribosome where it preferentially binds to the 50S ribosomal subunit, causing bacterial growth inhibition.

Adult

300-900 mg IV/IM q6h

Pediatric

Not established

Increases duration of neuromuscular blockade induced by tubocurarine and pancuronium; erythromycin may antagonize effects of clindamycin; antidiarrheals may delay absorption of clindamycin

Documented hypersensitivity; regional enteritis; ulcerative colitis; hepatic impairment; antibiotic-associated colitis

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Adjust dose in severe hepatic dysfunction; no adjustment is necessary in renal insufficiency; associated with severe and possibly fatal colitis; caution in neonates


Ampicillin (Marcillin, Omnipen, Polycillin, Principen, Totacillin)

Interferes with bacterial cell wall synthesis during active multiplication, causing bactericidal activity against susceptible organisms.

Adult

1-2 g PO divided qid
2-8 g IV/IM divided qid

Pediatric

Not established

Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction


Amoxicillin (Trimox, Amoxil, Biomox)

Can be used PO when outpatient treatment is indicated. Interferes with the synthesis of cell wall mucopeptide during active multiplication, resulting in a bactericidal activity against susceptible bacteria.

Adult

500 mg PO tid

Pediatric

Not established

Reduces efficacy of oral contraceptives

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Adjust dose in renal impairment


Ciprofloxacin (Cipro)

Fluoroquinolone with activity against pseudomonads, streptococci, MRSA, Staphylococcus epidermidis, and most gram-negative organisms but no activity against anaerobes. Inhibits bacterial DNA synthesis and, consequently, growth.

Adult

250-500 mg PO q12h
200-400 mg IV q12h

Pediatric

<18 years: Not recommended
>18 years: Administer as in adults

Antacids, iron salts, and zinc salts may reduce serum levels; administer antacids 2-4 h before or after taking fluoroquinolones; cimetidine may interfere with metabolism of fluoroquinolones; ciprofloxacin reduces therapeutic effects of phenytoin; probenecid may increase ciprofloxacin serum concentrations; may increase toxicity of theophylline, caffeine, cyclosporine, and digoxin (monitor digoxin levels); may increase effects of anticoagulants; monitor PT

Pregnancy

C - Safety for use during pregnancy has not been established.

Precautions

In prolonged therapy, perform periodic evaluations of organ system functions (eg, renal, hepatic, hematopoietic); adjust dose in renal function impairment; superinfections may occur with prolonged or repeated antibiotic therapy


Imipenem and cilastin (Primaxin)

Used for treatment of multiple organism infections as in peritonitis when other agents are not appropriate.

Adult

250-500 mg IV q6h

Pediatric

<12 years: Not recommended
>12 years: Not established

Coadministration with cyclosporine may increase CNS adverse effects of both agents; coadministration with ganciclovir may result in generalized seizures

Pregnancy

C - Safety for use during pregnancy has not been established.

Precautions

Adjust dose in renal insufficiency


Cefoxitin (Mefoxin)

Second-generation cephalosporin indicated for gram-positive cocci and gram-negative rod infections. Infections caused by cephalosporin-resistant or penicillin-resistant gram-negative bacteria may respond to cefoxitin.

Adult

1-2 g IV/IM q6-8h or 1-2 g IV/IM q4h in severe cases

Pediatric

Not established

Probenecid may increase effects of cefoxitin; coadministration with aminoglycosides or furosemide may increase nephrotoxicity (closely monitor renal function)

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Bacterial or fungal overgrowth of nonsusceptible organisms may occur with prolonged use or repeated treatment; caution in patients with previously diagnosed colitis


Ticarcillin and clavulanate potassium (Timentin)

Inhibits biosynthesis of cell wall mucopeptide and is effective during the stage of active growth. Antipseudomonal penicillin plus beta-lactamase inhibitor that provides coverage against most gram-negative bacteria and most anaerobes.

Adult

3 g ticarcillin and 0.1 g clavulanate IV over 30 min q4-6h

Pediatric

Not established

Tetracyclines may decrease effects of ticarcillin; high concentrations of ticarcillin may physically inactivate aminoglycosides if administered in same IV line; effects when administered concurrently with aminoglycosides are synergistic; probenecid may increase penicillin levels

Documented hypersensitivity; severe pneumonia; bacteremia; pericarditis; emphysema; meningitis; treatment of purulent or septic arthritis with oral penicillin during acute stage

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Perform CBC count prior to initiation of therapy and at least weekly during therapy; monitor for liver function abnormalities by measuring AST and ALT during therapy; exercise caution in patients diagnosed with hepatic insufficiencies; perform urinalysis and BUN and creatinine determinations during therapy and adjust dose if values become elevated; monitor blood levels to avoid possible neurotoxic reactions


Ampicillin and sulbactam sodium (Unasyn)

Drug combination antimicrobial agents consisting of a beta-lactamase inhibitor and ampicillin. Active against skin, enteric flora, and anaerobes.

Adult

1 g ampicillin and 0.5 g sulbactam IV q6h or 2 g ampicillin and 1 g sulbactam IV q6h

Pediatric

Not established

Probenecid and disulfiram elevate ampicillin levels; allopurinol decreases ampicillin effects and has additive effects on ampicillin rash; may decrease effects of oral contraceptives

Pregnancy

B - Usually safe but benefits must outweigh the risks.

Precautions

Adjust dose in renal failure; evaluate rash and differentiate from hypersensitivity reaction

More on Diverticulosis, Small Intestinal

Overview: Diverticulosis, Small Intestinal
Differential Diagnoses & Workup: Diverticulosis, Small Intestinal
Treatment & Medication: Diverticulosis, Small Intestinal
Follow-up: Diverticulosis, Small Intestinal
References

References

  1. Akhrass R, Yaffe MB, Fischer C. Small-bowel diverticulosis: perceptions and reality. J Am Coll Surg. Apr 1997;184(4):383-8. [Medline].

  2. Carey EJ, Fleischer DE. Investigation of the small bowel in gastrointestinal bleeding--enteroscopy and capsule endoscopy. Gastroenterol Clin North Am. Dec 2005;34(4):719-34. [Medline].

  3. Donald JW. Major complications of small bowel diverticula. Ann Surg. Aug 1979;190(2):183-8. [Medline].

  4. Eckhauser FE, Zelenock GB, Freier DT. Acute complications of jejuno-ileal pseudodiverticulosis: surgical implications and management. Am J Surg. Aug 1979;138(2):320-3. [Medline].

  5. Harford VH. Diverticula. In: Feldman M, Scharschmidt BF, Zorab R, Sleisenger MH, eds. Sleisenger and Fordtran's Gastrointestinal and Liver Disease: Pathophysiology/Diagnosis/Management. 6th ed. Philadelphia, Pa:. WB Saunders and Co;1998.

  6. Hartmann D, Schmidt H, Bolz G. A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding. Gastrointest Endosc. Jun 2005;61(7):826-32. [Medline].

  7. Isselbacher KJ, Ebstein A. Diverticular, vascular and other disorders of the intestine and peritoneum. In: Fauci A, ed. Harrison's Principles of Internal Medicine. New York, NY:. McGraw-Hill Inc;1998:1648-1649.

  8. Mark B. Small Intestine. In: Seymour I, Schwartz G, eds. Principles of Surgery. New York, NY:. McGraw-Hill Inc;1999:1247-1249.

  9. Rubesin SE. Simplified approach to differential diagnosis of small bowel abnormalities. Radiol Clin North Am. Mar 2003;41(2):343-64, vii. [Medline].

  10. Sanford JP, Gilbert DN, Moellering RC. The Sanford Guide to Antimicrobial Therapy 1999. USA Antibiotic Therapy Incorporation. 1999;02-1333. [Full Text].

Further Reading

Keywords

diverticular disease of the small bowel, mucosal herniations, abnormalities in peristalsis, intestinal dyskinesis, high segmental intraluminal pressures, true diverticula, false diverticula, Meckel's diverticulum, intraluminal diverticula, extraluminal diverticula, duodenal diverticula, jejunal diverticula, ileal diverticula, jejunoileal diverticula, diverticulitis, GI hemorrhage, intestinal obstruction, acute perforation, pancreatic disease, biliary disease

Contributor Information and Disclosures

Author

Lisa Ozick, MD, Chief, Division of Gastroenterology, Harlem Hospital Center
Lisa Ozick, MD is a member of the following medical societies: American Association for the Advancement of Science, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Medical Association, American Society for Gastrointestinal Endoscopy, and Phi Beta Kappa
Disclosure: Nothing to disclose.

Coauthor(s)

Rohan C Clarke, MD, Attending Gastroenterologist, JPS Health Systems Hospital, Fort Worth, Texas
Rohan C Clarke, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society of Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Oluyinka S Adediji, MD, Consulting Staff, Department of Adult and General Medicine, Health Services Incorporated, Montgomery, Alabama
Oluyinka S Adediji, MD is a member of the following medical societies: American College of Physicians and American Medical Association
Disclosure: Nothing to disclose.

Medical Editor

David Eric Bernstein, MD, Chief, Section of Hepatology, North Shore University Hospital, Director, Associate Professor, Department of Internal Medicine, Division of Hepatology, New York University School of Medicine
David Eric Bernstein, MD is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy
Disclosure: Nothing to disclose.

Pharmacy Editor

Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine
Disclosure: Nothing to disclose.

Managing Editor

Douglas M Heuman, MD, FACP, Director of Hepatology, McGuire Veterans Affairs Medical Center, Professor, Department of Internal Medicine, Division of Gastroenterology, Virginia Commonwealth University School of Medicine
Douglas M Heuman, MD, FACP is a member of the following medical societies: American Association for the Study of Liver Diseases, American College of Physicians, and American Gastroenterological Association
Disclosure: Nothing to disclose.

CME Editor

Alex J Mechaber, MD, FACP, Assistant Dean for Medical Curriculum, Associate Professor of Medicine, Division of General Internal Medicine, University of Miami Miller School of Medicine
Alex J Mechaber, MD, FACP is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians-American Society of Internal Medicine, and Society of General Internal Medicine
Disclosure: Nothing to disclose.

Chief Editor

Julian Katz, MD, Clinical Professor of Medicine, Drexel University College of Medicine; Consulting Staff, Department of Medicine, Section of Gastroenterology and Hepatology, Hospital of the Medical College of Pennsylvania
Julian Katz, MD is a member of the following medical societies: American College of Gastroenterology, American College of Physicians, American Gastroenterological Association, American Geriatrics Society, American Medical Association, American Society for Gastrointestinal Endoscopy, American Society of Law Medicine and Ethics, American Trauma Society, Association of American Medical Colleges, and Physicians for Social Responsibility
Disclosure: Nothing to disclose.

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.